vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Revolve Group, Inc. (RVLV). Click either name above to swap in a different company.
Revolve Group, Inc. is the larger business by last-quarter revenue ($324.4M vs $168.4M, roughly 1.9× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 10.4%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 9.5%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Revolve Theatre Company is a Henley-on-Thames based theatre company specialising in political and Shakespearean plays. The company is owned by Oliver Dench, Joe Morris and Tom Smith.
ESPR vs RVLV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $324.4M |
| Net Profit | — | $18.6M |
| Gross Margin | — | 53.3% |
| Operating Margin | 50.6% | 6.3% |
| Net Margin | — | 5.7% |
| Revenue YoY | 143.7% | 10.4% |
| Net Profit YoY | — | 50.4% |
| EPS (diluted) | $0.32 | $0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $324.4M | ||
| Q3 25 | $87.3M | $295.6M | ||
| Q2 25 | $82.4M | $309.0M | ||
| Q1 25 | $65.0M | $296.7M | ||
| Q4 24 | $69.1M | $293.7M | ||
| Q3 24 | $51.6M | $283.1M | ||
| Q2 24 | $73.8M | $282.5M | ||
| Q1 24 | $137.7M | $270.6M |
| Q4 25 | — | $18.6M | ||
| Q3 25 | $-31.3M | $21.2M | ||
| Q2 25 | $-12.7M | $10.2M | ||
| Q1 25 | $-40.5M | $11.8M | ||
| Q4 24 | — | $12.3M | ||
| Q3 24 | $-29.5M | $11.0M | ||
| Q2 24 | $-61.9M | $15.4M | ||
| Q1 24 | $61.0M | $10.9M |
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | 54.0% | ||
| Q1 24 | — | 52.3% |
| Q4 25 | 50.6% | 6.3% | ||
| Q3 25 | -11.4% | 7.1% | ||
| Q2 25 | 8.6% | 5.8% | ||
| Q1 25 | -34.0% | 5.0% | ||
| Q4 24 | -6.4% | 3.9% | ||
| Q3 24 | -31.0% | 5.0% | ||
| Q2 24 | 3.5% | 5.8% | ||
| Q1 24 | 52.5% | 3.4% |
| Q4 25 | — | 5.7% | ||
| Q3 25 | -35.9% | 7.2% | ||
| Q2 25 | -15.4% | 3.3% | ||
| Q1 25 | -62.2% | 4.0% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | -57.2% | 3.9% | ||
| Q2 24 | -83.9% | 5.4% | ||
| Q1 24 | 44.3% | 4.0% |
| Q4 25 | $0.32 | $0.27 | ||
| Q3 25 | $-0.16 | $0.29 | ||
| Q2 25 | $-0.06 | $0.14 | ||
| Q1 25 | $-0.21 | $0.16 | ||
| Q4 24 | $-0.14 | $0.18 | ||
| Q3 24 | $-0.15 | $0.15 | ||
| Q2 24 | $-0.33 | $0.21 | ||
| Q1 24 | $0.34 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $292.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $512.5M |
| Total Assets | $465.9M | $765.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $292.3M | ||
| Q3 25 | $92.4M | $315.4M | ||
| Q2 25 | $86.1M | $310.7M | ||
| Q1 25 | $114.6M | $300.8M | ||
| Q4 24 | $144.8M | $256.6M | ||
| Q3 24 | $144.7M | $252.8M | ||
| Q2 24 | $189.3M | $244.7M | ||
| Q1 24 | $226.6M | $273.4M |
| Q4 25 | $-302.0M | $512.5M | ||
| Q3 25 | $-451.4M | $490.2M | ||
| Q2 25 | $-433.5M | $468.6M | ||
| Q1 25 | $-426.2M | $453.4M | ||
| Q4 24 | $-388.7M | $437.8M | ||
| Q3 24 | $-370.2M | $420.8M | ||
| Q2 24 | $-344.2M | $405.8M | ||
| Q1 24 | $-294.3M | $389.9M |
| Q4 25 | $465.9M | $765.0M | ||
| Q3 25 | $364.0M | $751.3M | ||
| Q2 25 | $347.1M | $722.9M | ||
| Q1 25 | $324.0M | $713.9M | ||
| Q4 24 | $343.8M | $665.5M | ||
| Q3 24 | $314.1M | $670.9M | ||
| Q2 24 | $352.3M | $657.8M | ||
| Q1 24 | $373.1M | $650.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $-10.2M |
| Free Cash FlowOCF − Capex | — | $-13.3M |
| FCF MarginFCF / Revenue | — | -4.1% |
| Capex IntensityCapex / Revenue | 0.0% | 1.0% |
| Cash ConversionOCF / Net Profit | — | -0.55× |
| TTM Free Cash FlowTrailing 4 quarters | — | $48.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $-10.2M | ||
| Q3 25 | $-4.3M | $11.8M | ||
| Q2 25 | $-31.4M | $12.6M | ||
| Q1 25 | $-22.6M | $45.1M | ||
| Q4 24 | $-35.0M | $3.9M | ||
| Q3 24 | $-35.3M | $9.1M | ||
| Q2 24 | $-7.2M | $-24.7M | ||
| Q1 24 | $53.8M | $38.4M |
| Q4 25 | — | $-13.3M | ||
| Q3 25 | — | $7.5M | ||
| Q2 25 | — | $10.4M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | $-35.5M | $8.0M | ||
| Q2 24 | $-7.3M | $-25.7M | ||
| Q1 24 | $53.8M | $36.7M |
| Q4 25 | — | -4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | -68.7% | 2.8% | ||
| Q2 24 | -9.9% | -9.1% | ||
| Q1 24 | 39.0% | 13.5% |
| Q4 25 | 0.0% | 1.0% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.0% | 0.6% | ||
| Q3 24 | 0.3% | 0.4% | ||
| Q2 24 | 0.1% | 0.4% | ||
| Q1 24 | 0.1% | 0.6% |
| Q4 25 | — | -0.55× | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | 0.88× | 3.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
